First Horizon Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

First Horizon Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-186	Closed	-$1K	–	1583
2015 Q1	$1K	Buy	186 +4	+2%	+$29	﹤0.01%	1477
2014 Q4	$1K	Buy	182 +3	+2%	+$24	﹤0.01%	1449
2014 Q3	$1K	Buy	+179	New	+$1.66K	﹤0.01%	1456

Other funds holding PDLI

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Horizon Advisors's PDLI Position: Q2 2015 in Review

First Horizon Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q2 2015, closing a stake of 186 shares — an estimated $1K sold.

First Horizon Advisors first reported a position in PDLI in Q3 2014 and held it in 3 quarters. The position peaked at $1K in Q1 2015. 204 funds tracked by Wall St. Rank hold PDLI as of Q2 2015.

First Horizon Advisors reported no remaining PDL BioPharma, Inc. position as of Q2 2015 after selling out during the quarter.
First Horizon Advisors sold 186 PDL BioPharma, Inc. shares in Q2 2015, an estimated $1K.
First Horizon Advisors first reported a position in PDL BioPharma, Inc. in Q3 2014 and held it in 3 quarters.
First Horizon Advisors's PDL BioPharma, Inc. position peaked at $1K in Q1 2015.
204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2015.

Based on First Horizon Advisors's 13F filing for Q2 2015, filed 31 Jul 2015.